British Journal of Cancer - Table of Contents alert Volume 118 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 118, Issue 5 (March 2018) In this issue Editorial Review Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Epidemiology Letters to the Editor Also new AOP   Sign up for e-alerts Recommend to your library Web feed Subscribe   Advertisement Breast Cancer Now Catalyst Programme Grants  Apply now  We are inviting Expressions of Interest from researchers who are interested in using Pfizer drugs for preclinical or clinical breast cancer research from teams based at a single site or multiple sites in the UK and Europe. To apply please visit our website.   Editorial EQUATOR-Oncology: reducing the latitude of cancer trial design and reporting Habeeb Majeed & Eitan Amir British Journal of Cancer 2018 118 :617 - 618; February 22, 2018; 10.1038/bjc.2017.427   Abstract | Full Text Review Reporting guidelines for oncology research: helping to maximise the impact of your research Angela MacCarthy, Shona Kirtley, Jennifer A de Beyer, Douglas G Altman & Iveta Simera British Journal of Cancer 2018 118 :619 - 628; February 22, 2018; 10.1038/bjc.2017.407   Abstract | Full Text Clinical Studies Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology) S Rim Kim, Nan Song, Greg Yothers, Patrick G Gavin, Carmen J Allegra et al. British Journal of Cancer 2017 118 :629 - 633; December 14, 2017; 10.1038/bjc.2017.448   Abstract | Full Text Indeterminate nodules in osteosarcoma: what's the follow-up? K M Ghosh, L H Lee, T B Beckingsale, C H Gerrand & K S Rankin British Journal of Cancer 2018 118 :634 - 638; January 30, 2018; 10.1038/bjc.2017.453   Abstract | Full Text Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer Maite Antonio, Juana Saldaña, Jennifer Linares, José C Ruffinelli, Ramón Palmero et al. British Journal of Cancer 2018 118 :639 - 647; January 30, 2018; 10.1038/bjc.2017.455   Abstract | Full Text Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07) Jong-Mu Sun, Ki Hyeong Lee, Bong-Seog Kim, Hoon-Gu Kim, Young Joo Min et al. British Journal of Cancer 2018 118 :648 - 653; January 30, 2018; 10.1038/bjc.2017.465   Abstract | Full Text Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302) Baohui Han, Kai Li, Yizhuo Zhao, Baolan Li, Ying Cheng et al. British Journal of Cancer 2018 118 :654 - 661; February 13, 2018; 10.1038/bjc.2017.478   Abstract | Full Text KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study Yutaka Nakano, Minoru Kitago, Sachiko Matsuda, Yuki Nakamura, Yusuke Fujita et al. British Journal of Cancer 2018 118 :662 - 669; January 23, 2018; 10.1038/bjc.2017.479   Abstract | Full Text Translational Therapeutics WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages Geun Taek Lee, Seok Joo Kwon, Jongmyung Kim, Young Suk Kwon, Nara Lee et al. British Journal of Cancer 2018 118 :670 - 678; January 30, 2018; 10.1038/bjc.2017.451   Abstract | Full Text Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection Marie Viala, Marie Vinches, Marie Alexandre, Caroline Mollevi, Anna Durigova et al. British Journal of Cancer 2018 118 :679 - 697; February 13, 2018; 10.1038/bjc.2017.473   Abstract | Full Text Molecular Diagnostics The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma Laura Forker, Piers Gaunt, Stefano Sioletic, Patrick Shenjere, Robert Potter et al. British Journal of Cancer 2017 118 :698 - 704; December 12, 2017; 10.1038/bjc.2017.430   Abstract | Full Text The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer Meera Patel, Stephen T McSorley, James H Park, Campbell S D Roxburgh, Joann Edwards et al. British Journal of Cancer 2018 118 :705 - 712; January 16, 2018; 10.1038/bjc.2017.441   Abstract | Full Text Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein Urszula L McClurg, Arash Nabbi, Charles Ricordel, Svitlana Korolchuk, Stuart McCracken et al. British Journal of Cancer 2018 118 :713 - 726; January 30, 2018; 10.1038/bjc.2017.447   Abstract | Full Text Genetics & Genomics Telomere length and genetics are independent colorectal tumour risk factors in an evaluation of biomarkers in normal bowel Ceres Fernandez-Rozadilla, Christiana Kartsonaki, Connor Woolley, Michael McClellan, Deb Whittington et al. British Journal of Cancer 2018 118 :727 - 732; February 13, 2018; 10.1038/bjc.2017.486   Abstract | Full Text Epidemiology Which patients are not included in the English Cancer Waiting Times monitoring dataset, 2009–2013? Implications for use of the data in research C Di Girolamo, S Walters, C Gildea, S Benitez Majano, M P Coleman et al. British Journal of Cancer 2018 118 :733 - 737; January 18, 2018; 10.1038/bjc.2017.452   Abstract | Full Text Loss in working years after a breast cancer diagnosis Anna Plym, Hannah Bower, Irma Fredriksson, Lars Holmberg, Paul C Lambert et al. British Journal of Cancer 2018 118 :738 - 743; January 23, 2018; 10.1038/bjc.2017.456   Abstract | Full Text Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study Caron Strahlendorf, Jason D Pole, Randy Barber, David Dix, Ketan Kulkarni et al. British Journal of Cancer 2018 118 :744 - 749; January 30, 2018; 10.1038/bjc.2017.462   Abstract | Full Text External validation of risk prediction models for incident colorectal cancer using UK Biobank J A Usher-Smith, A Harshfield, C L Saunders, S J Sharp, J Emery et al. British Journal of Cancer 2018 118 :750 - 759; January 30, 2018; 10.1038/bjc.2017.463   Abstract | Full Text Letters to the Editor Comment on '30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure' Mohan Doss British Journal of Cancer 2018 118 : e9; February 13, 2018; 10.1038/bjc.2017.481   Abstract | Full Text Reply to 'Comment on '30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure'' Wan-Hua Hsieh, I-Feng Lin, Jung-Chun Ho & Peter Wushou Chang British Journal of Cancer 2018 118 : e10; February 13, 2018; 10.1038/bjc.2017.490   Abstract | Full Text Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis' Rama Jayaraj & Chellan Kumarasamy British Journal of Cancer 2018 118 : e11; February 15, 2018; 10.1038/bjc.2017.482   Abstract | Full Text Reply to 'Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis" Alhadi Almangush, Ilkka Heikkinen, Antti A Mäkitie, Ricardo D Coletta, Esa Läärä et al. British Journal of Cancer 2018 118 : e12; February 15, 2018; 10.1038/bjc.2017.491   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.